Accelerator Returns October 15, Expanding Its Focus on Al, Healthcare Access and Community Impact

Translate to Spanish or other 102 languages!

AltaCair Foundation, in partnership with Genentech as the 2026 co-host, will host its fourth annual Accelerator summit on Thursday, October 15, 2026, from 8:00 a.m. to 12:00 p.m. at the Harlingen Convention Center. Image: @ HarlingenConventionCenter via Facebook. Logo source: altacareaccelerator.com for illustration purposes
AltaCair Foundation, in partnership with Genentech as the 2026 co-host, will host its fourth annual Accelerator summit on Thursday, October 15, 2026, from 8:00 a.m. to 12:00 p.m. at the Harlingen Convention Center. Image: @ HarlingenConventionCenter via Facebook. Logo source: altacareaccelerator.com for illustration purposes
- Advertisement -

EDINBURG, Texas – AltaCair Foundation, in partnership with Genentech as the 2026 co-host, will host its fourth annual Accelerator summit on Thursday, October 15, 2026, from 8:00 a.m. to 12:00 p.m. at the Harlingen Convention Center.

Accelerator 2026: Bridging Al & Health Outcomes will bring together healthcare, policy, nonprofit, technology and community leaders to explore how artificial intelligence can be used responsibly and practically to improve healthcare access, communication, and community health outcomes.

The half-day summit will feature keynote speakers and panel discussions focused on whole-person care, social determinants of health, social impact and stronger community collaboration.

- Advertisement -

“Artificial intelligence is rapidly changing healthcare, but the conversation must remain centered on people,” said Dr. Rashmi Chandran, CEO of AltaCair Foundation. “Accelerator 2026 will create space for leaders across sectors to explore how innovation can help remove barriers, strengthen access and improve health outcomes for communities throughout the Rio Grande Valley.”

Accelerator was created to bring regional leaders together around the issues shaping health and well-being in the Rio Grande Valley. Now entering its fourth year, the summit continues to turn conversation into collaboration and community-centered action.

About AltaCair Foundation

AltaCair Foundation is a Rio Grande Valley nonprofit organization working to create a healthier region by fostering collaborative partnerships that address the basic healthcare needs of underserved communities. Through community resource fairs, educational initiatives, regional convenings and access-focused programs, AltaCair connects organizations, resources and residents to create meaningful community impact.

- Advertisement -

Additional information regarding registration, speakers and sponsorship opportunities found at www.altacairaccelerator.com.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

The Simple Blood Draw Reshaping the Future of Alzheimer’s Care

Diagnosing dementias such as Alzheimer’s disease is a complex process. While we’ve gained significant ground in understanding how the disease affects the brain, clinicians must still rely on generalized cognitive tests and advanced brain scans to make a definitive diagnosis.

Exploring Facial Processing Differences in Autism

Some of the hallmark characteristics of autism are the tendencies to avoid looking at other’s faces and making less eye contact.

STHS’ Freestanding ERs Earn National Recognition for High-Quality Resuscitation Care

Sudden cardiac arrest is a life-threatening medical emergency that occurs when the heart unexpectedly stops beating, abruptly cutting off blood flow to the brain and other vital organs. It can strike anyone, at any age, often without warning.

New Lancet Commission Outlines Roadmap to Close the Gender Gap in Blood Disorders

A new report in The Lancet Haematology, led by Cleveland Clinic hematologist Bethany Samuelson Bannow, M.D., outlines practical strategies to improve diagnosis, care and outcomes globally for women and girls with hematological conditions, such as bleeding disorders, heavy menstrual bleeding, postpartum hemorrhage, thrombosis and maternal hematologic complications.
- Advertisement -